Effects of nebivolol versus bisoprolol on endothelial function in hypertensive patients

Experimental and Clinical Cardiology

Volumn 14, Issue 4, 2009, Pages 45-49

  Simova, Iana Ivaylova ^a   Todorova Konstantinova, Rumiana Radoslavova ^b   Denchev, Stefan Veselinov ^c  

^a National Cardiology Hospital   (Bulgaria)

^b Specialized University Cardiology Hospital   (Bulgaria)

^c UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Arterial hypertension; Bisoprolol; Endothelial function; Flow mediated dilation; Nebivolol

Indexed keywords

BISOPROLOL; NEBIVOLOL;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; ELECTROCARDIOGRAM; FEMALE; FLOW MEDIATED DILATION; HUMAN; HYPERTENSION; MALE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 77950805329     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Mancia G, De Backer G, Dominiczak A, et al; European Society of Hypertension; European Society of Cardiology. 2007 ESH-ESC Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press 2007;16:135-232. (Pubitemid 46924065)
2. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111-1115
3. Ercan E, Tengiz I, Ercan HE, Nalbantgil I. Left ventricular hypertrophy and endothelial functions in patients with essential hypertension. Coron Artery Dis 2003;14:541-544 (Pubitemid 39118006)
4. Millgard J, Lind L. Acute hypertension impairs endothelium-dependent vasodilation. Clin Sci (Lond) 1999;96:217-218
5. Palmieri V, Storto G, Arezzi E, et al. Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects. J Hum Hypertens 2005;19:941-950 (Pubitemid 41823783)
6. Lee KW, Blann AD, Lip GY. High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction. Am J Hypertens 2005;18:104-115
7. Ryden L, Standl E, Bartnik M, et al; Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Guideline on diabetes, pre-diabetes and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007;28:88-136.
8. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts), Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: Executive summary. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts). Eur Heart J 2007;28:2375-2414 (Pubitemid 47542237)
9. Corretti M, Anderson T, Benjamin E, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-265 (Pubitemid 34084631)
10. Simova I, Nossikov A, Denchev S. Interobserver and intraobserver variability of flow mediated vasodilatation of the brachial artery. Echocardiography 2008;25:77-83.
11. Hornig B, Arakawa N, Haussmann D, Drexler H. Differential effects of quinaprilat and enalaprilat on endothelial function of conduit arteries in patients with chronic heart failure. Circulation 1998;98:2842-2848 (Pubitemid 29003965)
12. Cheetham C, O'Driscoll G, Stanton K, Taylor R, Green D. Losartan, an angiotensin type 1 receptor antagonist, improves conduit vessel endothelial function in type II diabetes. Clin Sci (Lond) 2001;100:13-17 (Pubitemid 32057802)
13. Taddei S, Virdis A, Ghiadoni L, Uleri S, Magagna A, Salvetti A. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients. Hypertension 1997;30:1606-1612 (Pubitemid 27528112)
14. Ghiadoni L, Magagna A, Versari D, et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003;41:1281-1286 (Pubitemid 36706078)
15. Flammer AJ, Hermann F, Wiesli P, et al. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension. J Hypertens 2007;25:785-791 (Pubitemid 46398873)
16. 1-selectivity of three beta1-selective beta-blockers. J Clin Pharm Ther 2003;28:179-186
17. Ritter JM. Nebivolol: Endothelium-mediated vasodilating effect. J Cardiovasc Pharmacol 2001;38(Suppl 3):S13-6.
18. Lekakis JP, Protogerou A, Papamichael C, et al. Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease. Cardiovasc Drugs Ther 2005;19:277-281 (Pubitemid 41778808)
19. Czuriga I, Riecansky I, Bodnar J, et al. For The NEBIS Investigators; NEBIS Investigators Group. Comparison of the new cardioselective beta-blocker nebivolol with bisoprolol in hypertension: The Nebivolol, Bisoprolol Multicenter Study (NEBIS). Cardiovasc Drugs Ther 2003;17:257-263
20. Simova I, Denchev S. Endothelial functional and structural impairment in patients with different degree of coronary artery disease development. Heart and Vessels 2008;23:305-315